A detailed history of Altfest L J & CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Altfest L J & CO Inc holds 983 shares of REGN stock, worth $1.05 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
983
Previous 965 1.87%
Holding current value
$1.05 Million
Previous $848,000 11.56%
% of portfolio
0.13%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$902.69 - $993.35 $16,248 - $17,880
18 Added 1.87%
983 $946,000
Q4 2023

Jan 18, 2024

SELL
$775.18 - $881.7 $2,325 - $2,645
-3 Reduced 0.31%
965 $848,000
Q3 2023

Oct 26, 2023

BUY
$692.45 - $844.37 $4,847 - $5,910
7 Added 0.73%
968 $797,000
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $6,300 - $7,473
-9 Reduced 0.93%
961 $691,000
Q4 2022

Feb 02, 2023

SELL
$705.89 - $766.39 $8,470 - $9,196
-12 Reduced 1.22%
970 $700,000
Q3 2022

Nov 15, 2022

BUY
$573.97 - $724.32 $10,905 - $13,762
19 Added 1.97%
982 $676,000
Q1 2022

May 02, 2022

BUY
$595.12 - $698.43 $21,424 - $25,143
36 Added 3.88%
963 $673,000
Q4 2021

Jan 24, 2022

BUY
$543.48 - $670.97 $1,630 - $2,012
3 Added 0.32%
927 $585,000
Q3 2021

Oct 12, 2021

SELL
$574.03 - $680.96 $4,018 - $4,766
-7 Reduced 0.75%
924 $559,000
Q2 2021

Jul 28, 2021

SELL
$472.8 - $558.54 $6,619 - $7,819
-14 Reduced 1.48%
931 $520,000
Q1 2021

May 07, 2021

BUY
$446.73 - $548.2 $422,159 - $518,049
945 New
945 $447,000
Q1 2020

Apr 13, 2020

SELL
$336.18 - $494.43 $435,016 - $639,792
-1,294 Closed
0 $0
Q4 2019

Jan 06, 2020

SELL
$274.13 - $376.51 $124,455 - $170,935
-454 Reduced 25.97%
1,294 $486,000
Q3 2019

Oct 10, 2019

BUY
$273.46 - $318.39 $7,930 - $9,233
29 Added 1.69%
1,748 $485,000
Q2 2019

Jul 15, 2019

BUY
$299.6 - $414.82 $515,012 - $713,075
1,719 New
1,719 $538,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $115B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.